Chemical activators of LOC100132963 include a variety of compounds that influence intracellular signaling pathways leading to its activation. Forskolin raises intracellular cAMP levels by activating adenylyl cyclase, which in turn activates protein kinase A (PKA). PKA then can phosphorylate LOC100132963, thereby switching on its functional activity within the cells. Similarly, Dibutyryl-cAMP, a cAMP analog, activates PKA that can target LOC100132963 for phosphorylation and activation. Phorbol 12-myristate 13-acetate (PMA) is another activator that operates through the protein kinase C (PKC) pathway, where PKC can directly phosphorylate LOC100132963 as a part of its signaling cascade. 1,2-Dioctanoyl-sn-glycerol, a synthetic analog of diacylglycerol, also activates PKC, which then can lead to the phosphorylation and subsequent activation of LOC100132963.
The increase in intracellular calcium levels is another pathway that can lead to the activation of LOC100132963. Ionomycin and A23187 both act to increase intracellular calcium concentrations, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases have the capacity to phosphorylate LOC100132963, activating it. Thapsigargin, by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), also raises cytosolic calcium levels, which may activate kinases that target LOC100132963. Inhibitors of protein phosphatases, such as Calyculin A and Okadaic Acid, prevent the dephosphorylation of proteins, which can result in a net increase in phosphorylation and activation of LOC100132963. Anisomycin activates stress-activated protein kinases (SAPKs), which may phosphorylate and activate LOC100132963. Bisindolylmaleimide I, although primarily a PKC inhibitor, can lead to the compensatory activation of alternative kinases that might phosphorylate and activate LOC100132963. Lastly, Brefeldin A disrupts protein transport, and the resulting cellular adaptations can include the activation of kinases, which could lead to the activation of LOC100132963. Each chemical engages with a specific cellular pathway that converges on the phosphorylation state of LOC100132963, ensuring its functional activity is modulated according to the intracellular signaling dynamics.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). PKC phosphorylation events may directly activate LOC100132963 through phosphorylation within its associated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases may phosphorylate and activate LOC100132963. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to a net increase in protein phosphorylation. This can result in the activation of LOC100132963 through sustained phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, similar to Calyculin A, leading to increased phosphorylation and potential activation of LOC100132963. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs). Activation of SAPKs may lead to phosphorylation and activation of LOC100132963. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing a rise in cytosolic calcium levels that may activate kinases targeting LOC100132963. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, raising intracellular calcium levels and potentially activating kinases that phosphorylate and activate LOC100132963. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, a PKC inhibitor, may paradoxically activate alternate kinase pathways which could lead to the phosphorylation and activation of LOC100132963. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
This synthetic analog of diacylglycerol activates PKC, which may phosphorylate and activate LOC100132963 as part of the signaling cascade. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport, leading to signaling compensations that may involve kinase activation, potentially resulting in LOC100132963 activation. | ||||||